Research Article
Experimental Studies of Silicon in the Fight Against Pathogenic Microorganisms (Experimental and Clinical Studies)
Mavlyanova Sh.Z1, Mavlyanov P.N2, Maxsudov M.R.1, Mullahanov J.B1, Sobirkulov Sh.U1, and Atadjanov Sh.Yu1
1Republican Specialized Scientific and Practical Medical Center of Dermatovenerology and Cosmetology of the Ministry of Health of the Republic of Uzbekistan
2Institute of Hydrogeology and Engineering Geology
Mavlyanova Sh. Z, FRepublican Specialized Scientific and Practical Medical Center of Dermatovenerology and Cosmetology of the Ministry of Health of the Republic of Uzbekistan
Received Date: June 16, 2020; Published Date: June 25, 2020
Abstract
The article presents the results of chemical, clinical and experimental studies of siliceous solutions. Silicon as a trace element is biologically necessary for a living organism. Violation of the exchange of silicon in the human body leads to the development of a number of skin diseases - dermatitis, erysipelatous inflammation of the skin, etc. According to foreign authors, flint water helps the body compensate for the negative environmental factor (industrial, anthropogenic, etc.) aimed at increasing immunity and maintaining nervous systems; Spectrometric research methods have shown that activated siliceous waters contain a complex of chemical elements from Si, Ca, Mg, K, Na and REE, yttrium, uranium, thorium and scandium. The results of the study showed that siliceous solutions, due to the chemical composition of medicinal minerals and REE elements, contribute to the enrichment of the chelating protein calprotectin in neutrophils, which further inhibits the growth of mixed bacterial and viral microorganisms, which leads to anti-infection efficiency
Keywords:Silicon, Opportunistic Skin Infections, Viruses, Staphylococci, Candida Spp., Allergic Dermatoses, Colonization, Experimental Research
-
Mavlyanova Sh. Z*, Mavlyanov P. N, Maxsudov M.R. Experimental Studies of Silicon in the Fight Against Pathogenic Microorganisms (Experimental and Clinical Studies). Acad J Microbiol & Immun. 1(1): 2020. AJMI.MS.ID.000501.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.